Imraldi

E2049309 UNEXPLORED

Imraldi is a biosimilar medicine to adalimumab used to treat various inflammatory autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
Imraldi canonical 1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Samsung Bioepis hasProduct Imraldi